Mark J. Suto
Corporate Officer/Principal at Southern Research Institute
Profile
Mark J.
Suto currently works at American Chemical Society, as Member and Southern Research Institute, as Vice President-Drug Discovery Division from 2011.
Dr. Suto also formerly worked at DuPont Pharmaceuticals Co., as Executive Director-Chemistry from 1999 to 2002, Neusentis, Inc., as Vice President-Chemical & Pharmaceutical Sciences from 2009 to 2011, Neurion Pharmaceuticals, Inc., as Chief Scientific Officer & EVP in 2002, Deltagen Research Laboratories LLC, as Vice President-Chemical & Biological Sciences, and Parke-Davis Pharmaceutical Research, Inc., as Principal.
Dr. Suto received his undergraduate degree and doctorate degree from The State University of New York.
Mark J. Suto active positions
Companies | Position | Start |
---|---|---|
Southern Research Institute
Southern Research Institute Miscellaneous Commercial ServicesCommercial Services Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL. | Corporate Officer/Principal | 2011-08-17 |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Former positions of Mark J. Suto
Companies | Position | End |
---|---|---|
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Corporate Officer/Principal | 2011-07-31 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | 2001-12-31 |
Neurion Pharmaceuticals, Inc.
Neurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurion Pharmaceuticals, Inc. provides pharmaceutical products. It develops novel molecule drugs for the treatment of central nervous system disorders such as schizophrenia, chronic pain, and Alzheimer's disease. The company was co-founded by Dr. Henry A. Lester, William L. Robbins, and Dr. Dennis A. Dougherty in January, 2002 and is headquartered in Pasadena, CA. | Chief Tech/Sci/R&D Officer | 2001-12-31 |
Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | - |
Deltagen Research Laboratories LLC | Corporate Officer/Principal | - |
Training of Mark J. Suto
The State University of New York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 7 |
---|---|
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
Neurion Pharmaceuticals, Inc.
Neurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurion Pharmaceuticals, Inc. provides pharmaceutical products. It develops novel molecule drugs for the treatment of central nervous system disorders such as schizophrenia, chronic pain, and Alzheimer's disease. The company was co-founded by Dr. Henry A. Lester, William L. Robbins, and Dr. Dennis A. Dougherty in January, 2002 and is headquartered in Pasadena, CA. | Health Technology |
Southern Research Institute
Southern Research Institute Miscellaneous Commercial ServicesCommercial Services Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL. | Commercial Services |
Deltagen Research Laboratories LLC | |
Parke-Davis Pharmaceutical Research, Inc. |
- Stock Market
- Insiders
- Mark J. Suto